[ad_1]
MarketResearchNest.com adds the new report "The Global Hepatitis A Vaccine Market 2019 by Manufacturer, Region, Type and Application, Forecast to 2024" to its search database. The report is spread over 123 pages containing tables and figures.
This press release was originally distributed by SBWire
Pune, India – (SBWIRE) – 15/02/2019 – The vaccine against hepatitis A is a vaccine against the hepatitis A virus. The vaccine against hepatitis A is available for the long-term prevention of HAV infection. The minimum age for vaccination against HAV is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Vaccines inactivated by formaldehyde: Inactivated vaccines against HAV are used in most countries. Monovalent inactivated HAV vaccines are available in pediatric doses (0.5 ml) for children aged 1 to 15 years and in adult doses (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the Indian private sector.
Scope of the report:
The vaccine against hepatitis A is a vaccine against the hepatitis A virus. The vaccine against hepatitis A is available for the long-term prevention of HAV infection. The minimum age for vaccination against HAV is 1 year.
The clbadification of hepatitis A vaccine includes inactivated vaccine, live attenuated vaccine, and the proportion of inactivated vaccine sales in 2017 is about 70.8%, and this proportion is increasing from 2013 to 2018 .
Inactivated vaccines: Inactivated vaccines against HAV are used in most countries. Monovalent inactivated HAV vaccines are available in pediatric doses (0.5 ml) for children aged 1 to 15 years and in adult doses (1 ml).
The global market for hepatitis A vaccine is expected to grow by about 2.8% over the next five years, reaching US $ 770 million in 2024, up from US $ 650 million in 2019.
This report focuses on the hepatitis A vaccine in the global market, particularly in North America, Europe and Asia-Pacific, South America, the Middle East and Africa. This report ranks the market by manufacturer, region, type, and application.
Request a copy copy at
https://www.marketresearchnest.com/report/requestsample/535651
Market segment by manufacturers, this report covers
– GSK
– Merck
– Sanofi
– Sinovac
– Zhejiang Pukang
– Changchun Biology Institute
– Kaketsuken
– IMBCA
– ChangSheng
– Convac
Market segment by regions, regional badysis covers
– North America (United States, Canada and Mexico)
– Europe (Germany, France, United Kingdom, Russia and Italy)
– Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
– South America (Brazil, Argentina, Colombia, etc.)
– Middle East and Africa (Saudi Arabia, Egypt, Nigeria, South Africa, United Arab Emirates)
Market segment by type, covers
– Inactivated vaccine
– Live attenuated vaccine
Market segment by applications, can be divided into
– Governmental institution
– Private sector
– Other
Browse the complete table of contents and data tables on
https://www.marketresearchnest.com/Global-Hepatitis-A-Vaccine-Market-2019-by-Manufacturers-Regions-Type-and-Application-Forecast-to-2024.html
There are 15 chapters to display in depth the global market for the vaccine against hepatitis A.
Chapter 1 describes the introduction of hepatitis A vaccine, product definition, market overview, market opportunities, market risk, market driving force;
Chapter 2, to badyze leading manufacturers of hepatitis A vaccines, with sales, revenues and price of hepatitis A vaccine in 2016 and 2017;
Chapter 3, which presents the competitive situation of the major manufacturers, with their sales, revenues and market shares in 2016 and 2017;
Chapter 4, presenting the global market by regions, with sales, turnover and market share of the hepatitis A vaccine, for each region, from 2013 to 2019;
Chapters 5, 6, 7, 8 and 9 badyze the market by country, by type, by application and by manufacturer, with sales, turnover and market shares of the main countries in these regions;
Chapters 10 and 11 present the market by type and by application, with the market share of sales and the growth rate by type and by application, from 2013 to 2019;
Chapter 12, Hepatitis A Vaccine Market Forecast, by Region, Type and Application, Sales and Sales, 2019-2024;
Chapters 13, 14 and 15 describe the sales pipeline of hepatitis A vaccine, distributors, traders, dealers, search results and conclusion, appendix and source of data.
Order a copy of the purchase report at
https://www.marketresearchnest.com/report/purchase/535651
About MarketResearchNest.com
MarketResearchNest.com is the most comprehensive collection of market research products and services available on the Web. We offer reports from almost every major publisher and update our collection daily to provide you with instant online access to the world's most comprehensive and up-to-date database of expert information on sectors, organizations, products and trends. world.
Contact us
Mr. Jeet Jain
Commercial director
[email protected]
+ 1-240-284-8070 (United States)
+ 44-20-3290-4151 (U.K)
Connect with us: Google+ | LinkedIn | Twitter | Facebook
For more information on this press release, visit: http://www.sbwire.com/press-releases/hepatitis-in-vaccine-market-2019-global-badysis-by-key-players-gsk -merck-sanofi-sinovac -zhejiang-pukang-changchun-institute-of-biological-kaketsuken-imbca-1147901.htm
[ad_2]
Source link
